U.S. Pharma Stock News

Ameriprise Financial (NYSE:AMP) is in a legal dispute with LPL Financial involving advisor transitions and data access. A federal appeals court has allowed a group of advisors to intervene in the case and pause searches of their personal devices. The ruling is tied to ongoing FINRA arbitration, which is shaping how evidence and advisor rights are handled. Ameriprise Financial, trading at about $485.96, enters this dispute with a mixed return profile, including a 44.7% gain over 3 years and...

IQVIA Holdings (NYSE:IQV) and Duke Clinical Research Institute entered a collaboration focused on obesity and cardiometabolic clinical trials. The partnership combines IQVIA's global trial operations with DCRI's academic research capabilities to support new therapies in these disease areas. The collaboration aims to broaden access to diverse patient groups and set benchmarks for clinical and scientific quality in future studies. For investors looking at NYSE:IQV, this move sits at the...

In early February 2026, TransDigm Group reported first‑quarter fiscal 2026 results showing higher sales of US$2,285 million but lower net income of US$445 million year over year, while also updating investors on its ongoing share repurchases and M&A pipeline. At the same time, management raised full‑year 2026 guidance for net sales, net income and earnings per share, highlighting confidence in demand and the company’s ability to deploy its sizable cash balance across reinvestment,...

In early February 2026, Centene Corporation reported fourth-quarter 2025 revenue of US$49.73 billion and a net loss of US$1.10 billion, with full-year 2025 revenue of US$194.78 billion and a net loss of US$6.67 billion. Alongside these results, Centene issued 2026 guidance calling for total revenue of US$186.50 billion to US$190.50 billion and GAAP diluted EPS of more than US$1.98, while highlighting margin improvement efforts and mixed membership trends across Medicaid and Commercial...

Citigroup’s downgrade of Schneider National (SNDR) from Neutral to Sell has put fresh attention on the stock, coming shortly after the company’s fourth quarter and full year 2025 earnings release. See our latest analysis for Schneider National. At a share price of US$29.72, Schneider National’s 90-day share price return of 36.64% and 30-day share price return of 3.34% suggest momentum had been building before Citigroup’s downgrade. The 1-year total shareholder return of 8.64% reflects a...

Corning (GLW) is back in focus after securing a supply agreement with Meta valued at up to US$6b for fiber optic cables serving AI data centers, highlighting its Optical Communications business. See our latest analysis for Corning. The Meta agreement has arrived at a time when sentiment around Corning has already been strong, with a 51.23% 30 day share price return and a very large 305.35% 3 year total shareholder return pointing to strong momentum rather than a short term spike. If Corning’s...

Carnival Corporation & (CCL) earnings surprises and operations in focus Carnival Corporation & (CCL) is back on investor radars after four straight quarters of positive earnings surprises, alongside fresh fleet wide operational agreements and new port development projects that spotlight ongoing business adjustments. See our latest analysis for Carnival Corporation &. Despite a small 1 day share price pullback, Carnival’s 90 day share price return of 26.59% and 1 year total shareholder return...

ExlService Holdings (NasdaqGS:EXLS) has received 10 new U.S. patents covering AI and data-focused solutions. The patents span multiple sectors, including insurance, healthcare, retail, utilities, and financial services. Newly protected capabilities target data readiness for AI, workflow automation, and tuning large language models for enterprise use. For shareholders watching NasdaqGS:EXLS, this patent batch lands after a challenging stretch for the stock, with the share price at $30.25 and...

Gen Digital Inc. recently reported third-quarter fiscal 2026 results, with sales rising to US$1,240 million and net income to US$192 million year on year, while also declaring a quarterly dividend of US$0.125 per share payable on March 11, 2026. Alongside these results, the company launched its Gen Agent Trust Hub to address emerging security risks from autonomous AI agents, signaling an effort to position its cyber safety platform at the center of the AI “agentic” ecosystem. We’ll now...

In early February 2026, Illumina reported fourth-quarter 2025 revenue of US$1,159 million and full-year 2025 revenue of US$4.34 billion, issued 2026 revenue guidance of US$4.5–4.6 billion, and closed its SomaLogic acquisition. At the same time, Illumina expanded its role in clinical and conservation genomics, including a sequencing agreement for up to 4,000 Frozen Zoo® samples with the San Diego Zoo Wildlife Alliance. Now we’ll examine how Illumina’s 2026 guidance, including the SomaLogic...

Kraft Heinz (NasdaqGS:KHC) has halted its planned company separation. The company is launching a $600 million investment program focused on marketing, product development, and operations. New CEO Steve Cahillane is steering this shift as part of an effort to focus on internal growth. Kraft Heinz enters this reset with a mixed recent record for shareholders. The share price is $24.99, with the stock up 6.8% over the past 30 days and 2.1% over the past week, but showing a 7.5% decline over 1...

Gartner (NYSE:IT) is selling its software review platforms Capterra, Software Advice, and GetApp to G2. The deal shifts ownership of three widely used B2B software discovery sites to a single operator in the sector. This transaction marks a change in Gartner's portfolio mix and reduces its direct exposure to software review marketplaces. For you as an investor, this move matters because Gartner has been known for both its research and its role in software buying decisions through these...

Motorola Solutions: why the recent move matters Motorola Solutions (MSI) has been drawing attention after its recent share price performance, prompting investors to look more closely at how its communications and security business might align with their portfolios. See our latest analysis for Motorola Solutions. The recent 9.2% 1-month share price return and 9.9% 3-month share price return at around $421.13 sit alongside a 1-year total shareholder return decline of 8.8% and a 5-year total...

If you are wondering whether Chipotle Mexican Grill’s share price still reflects its long term potential, you are not alone. This article focuses squarely on what you may be paying for today. The stock last closed at US$37.22, with returns of a 6.8% decline over 7 days, 7.7% decline over 30 days, 0.7% decline year to date and 35.0% decline over 1 year, compared with gains of 12.3% over 3 years and 27.5% over 5 years. Those mixed returns sit against a backdrop of ongoing interest in...

Upwork (NasdaqGS:UPWK) is integrating its Lifted enterprise platform into the core business while stepping up investment in artificial intelligence tools and services. The company recently reported financial results that showed weaker active client metrics and issued cautious guidance for the next quarter. Management highlighted AI driven impacts on pricing and transaction volumes as key headwinds alongside the shift toward a more enterprise focused model. These moves have raised questions...

Cohen & Steers plans to convert its Future of Energy Fund into an ETF. The shift aligns the firm with a broader move by traditional asset managers toward ETF structures. The conversion responds to changing investor preferences around access, fees, and trading flexibility. Cohen & Steers, listed as NYSE:CNS, is moving its Future of Energy Fund into an ETF format at a time when investors are paying close attention to listed asset managers and their product line ups. The shares most recently...

VeriSign, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher sales and net income year over year, while also announcing a quarterly dividend increase to US$0.81 per share and updating investors on progress under its long-running share repurchase program. Beyond the headline growth in revenue and earnings, the combination of a higher dividend and continued buybacks highlights management’s emphasis on returning cash to shareholders alongside its core internet...

Paramount Skydance (PSKY) has caught investor attention after its recent performance, with the share price last closing at US$11.01 and short term returns showing a mix of modest gains and declines across different time frames. See our latest analysis for Paramount Skydance. Those small recent share price gains, including a 1-day share price return of 1.57% and 7-day return of 2.42%, sit against a weaker backdrop, with a 30-day share price return showing a 9.38% decline and a 90-day share...

If you are wondering whether Neurocrine Biosciences is fairly priced or offering value right now, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$137.44, with returns of 3.6% over 30 days and 17.3% over 1 year. These figures can change how investors think about both its potential upside and its risk. Recent news coverage has focused on Neurocrine Biosciences as a key player in the US pharmaceuticals and biotech space, with...

If you are wondering whether Atlassian shares are starting to look interesting at today’s price, this article will walk through what the current market value actually reflects and what it might be missing. Atlassian’s share price closed at US$86.97, with returns of a 17.2% decline over 7 days, 40.6% decline over 30 days, 43.8% decline year to date and 72.7% decline over the past year. Even the 3 year and 5 year returns of 53.6% decline and 65.3% decline respectively show how much sentiment...

DexCom is rolling out new AI-driven upgrades to its Stelo glucose monitoring platform, including expanded Smart Food Logging tied to a broad nutrition database. The Stelo app is also adding a redesigned Daily Insights interface that offers personalized, coaching style guidance around food and lifestyle choices. These features are launching nationwide as part of DexCom's push to deepen engagement with consumer users of its glucose monitoring tools. For investors watching DexCom...

Boeing (NYSE:BA) reported a record January for aircraft orders and deliveries, outpacing Airbus. The company secured a long term C-17 modernization contract with the U.S. Air Force, with work planned through 2075. Boeing booked large commercial deals with customers including Delta Air Lines and Aviation Capital Group. The company is relocating jobs to South Carolina, triggering rising union concerns about possible layoffs. Boeing, a core player in global commercial aviation and defense, is...

If you are wondering whether Syndax Pharmaceuticals at US$21.71 is offering good value today, you are not alone. This article is here to unpack that question calmly and clearly. The stock has returned 6.3% over the last 7 days, 4.8% over 30 days, 1.9% year to date and 46.1% over the past year. However, the 3 year and 5 year returns of negative 16.5% and negative 5.0% show a more mixed longer term picture. These moves have arrived alongside ongoing interest in Syndax Pharmaceuticals' pipeline...

Mettler-Toledo International (MTD) has drawn investor interest after recent trading left the shares around $1,392.65, with a value score of 1 and mixed total returns over the past year and past 3 months. See our latest analysis for Mettler-Toledo International. With the share price at US$1,392.65, Mettler-Toledo’s recent 30 day share price return of a 6.66% decline and relatively flat 90 day move contrast with a 6.10% gain in 1 year total shareholder return and a 19.39% total shareholder...